BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 7690927)

  • 1. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
    Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
    Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains.
    Veillette A; Caron L; Fournel M; Pawson T
    Oncogene; 1992 May; 7(5):971-80. PubMed ID: 1570157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P56lck: a transducing protein that binds to SH2 containing proteins and to phosphotyrosine containing proteins.
    Ramos-Morales F; Douté M; Fischer S
    Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):695-700. PubMed ID: 7526919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Lck SH2 phosphotyrosine binding site is critical for efficient TCR-induced processive tyrosine phosphorylation of the zeta-chain and IL-2 production.
    Lewis LA; Chung CD; Chen J; Parnes JR; Moran M; Patel VP; Miceli MC
    J Immunol; 1997 Sep; 159(5):2292-300. PubMed ID: 9278318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lad, an adapter protein interacting with the SH2 domain of p56lck, is required for T cell activation.
    Choi YB; Kim CK; Yun Y
    J Immunol; 1999 Nov; 163(10):5242-9. PubMed ID: 10553045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding affinities of the SH2 domains of ZAP-70, p56lck and Shc to the zeta chain ITAMs of the T-cell receptor determined by surface plasmon resonance.
    Labadia ME; Ingraham RH; Schembri-King J; Morelock MM; Jakes S
    J Leukoc Biol; 1996 May; 59(5):740-6. PubMed ID: 8656061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The crystal structures of the SH2 domain of p56lck complexed with two phosphonopeptides suggest a gated peptide binding site.
    Mikol V; Baumann G; Keller TH; Manning U; Zurini MG
    J Mol Biol; 1995 Feb; 246(2):344-55. PubMed ID: 7532720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphorylation of GAP and GAP-associated proteins in lymphoid and fibroblast cells expressing lck.
    Ellis C; Liu XQ; Anderson D; Abraham N; Veillette A; Pawson T
    Oncogene; 1991 Jun; 6(6):895-901. PubMed ID: 1906156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic cell phosphatase (HCP) regulates p56LCK phosphorylation and ZAP-70 binding to T cell receptor zeta chain.
    Raab M; Rudd CE
    Biochem Biophys Res Commun; 1996 May; 222(1):50-7. PubMed ID: 8630073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck.
    Abraham N; Miceli MC; Parnes JR; Veillette A
    Nature; 1991 Mar; 350(6313):62-6. PubMed ID: 1706070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes.
    Hivroz C; Mazerolles F; Soula M; Fagard R; Graton S; Meloche S; Sekaly RP; Fischer A
    Eur J Immunol; 1993 Mar; 23(3):600-7. PubMed ID: 7680610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of the SH2 and SH3 domains of the lck tyrosine protein kinase.
    Reynolds PJ; Hurley TR; Sefton BM
    Oncogene; 1992 Oct; 7(10):1949-55. PubMed ID: 1408136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site.
    Huang N; Nagarsekar A; Xia G; Hayashi J; MacKerell AD
    J Med Chem; 2004 Jul; 47(14):3502-11. PubMed ID: 15214778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of tripartite chimeras between Src and Lck.
    Kashishian A; MacAuley A; Cooper JA
    Oncogene; 1990 Oct; 5(10):1463-70. PubMed ID: 2250908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS; Parsons JT
    Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor and CD8-dependent tyrosine phosphorylation events in cytotoxic T lymphocytes: activation of p56lck by CD8 binding to class I protein.
    Anel A; O'Rourke AM; Kleinfeld AM; Mescher MF
    Eur J Immunol; 1996 Oct; 26(10):2310-9. PubMed ID: 8898939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gp120 ligation of CD4 induces p56lck activation and TCR desensitization independent of TCR tyrosine phosphorylation.
    Goldman F; Jensen WA; Johnson GL; Heasley L; Cambier JC
    J Immunol; 1994 Oct; 153(7):2905-17. PubMed ID: 7522245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lymphocyte-specific protein tyrosine kinase p56lck is hyperphosphorylated on serine and tyrosine residues within minutes after activation via T cell receptor or CD2.
    Danielian S; Fagard R; Alcover A; Acuto O; Fischer S
    Eur J Immunol; 1989 Dec; 19(12):2183-9. PubMed ID: 2481585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.